Kucharczyk Piotr, Michałkiewicz Dariusz, Kucharczyk Aleksandra
Wojskowy Instytut Medyczny w Warszawie, Oddział Ratunkowy CSK MON.
Pol Merkur Lekarski. 2006 Jul;21(121):86-9.
The use of several groups of medications may result in thyroid dysfunction including thyrotoxicosis or hypothyroidism of various degree (from subclinical to full-clinical syndrome). The mentioned disturbances may develop either on the basis of normal euthyroid gland or may overlap the previously-existing oceult changes (first of all different forms of autoimmune thyroiditis). Amiodarone is a widely used anti-arrythmic drug with considerable potential to cause thyroid dysfunction because of its 35% iodine content. Besides amiodarone particles are known to inhibit T4 to T3 conversion, they work as inhibitors of nuclear receptors for thyroid hormones, exert cytotoxic effect and induce immune/inflammatory process in thyroid gland. Both thyrotoxicosis (AIT - amiodarone induced thyrotoxicosis) and hypothyroidism (AIH - amiodarone induce hypothyroidism) may develop during amiodarone therapy. AIT appears to occur more frequently in geographical areas with low iodine intake, whereas AIH is more frequent in iodine-sufficient areas. Two forms of AIT are known. Their differentiation is very important for further therapeutical procedures. Because thyrotoxicosis and hypothyroidism symptoms during amiodarone therapy are scanty, there is need for periodic determination of thyroid function. Normal ranges for amiodarone patients differ from those for the rest of population. They are presented in this review. Treatment of AIT is very complicated. Sometimes there is need to use few methods together, especially when amiodarone treatment can not be stopped.
使用几组药物可能会导致甲状腺功能障碍,包括各种程度的甲状腺毒症或甲状腺功能减退(从亚临床到全临床综合征)。上述紊乱可能在正常甲状腺功能的基础上发生,也可能与先前存在的隐匿性变化(首先是不同形式的自身免疫性甲状腺炎)重叠。胺碘酮是一种广泛使用的抗心律失常药物,因其含碘量达35%,有相当大的导致甲状腺功能障碍的可能性。此外,已知胺碘酮颗粒会抑制T4向T3的转化,它们作为甲状腺激素核受体的抑制剂起作用,发挥细胞毒性作用并在甲状腺中诱导免疫/炎症过程。在胺碘酮治疗期间,甲状腺毒症(AIT - 胺碘酮诱导的甲状腺毒症)和甲状腺功能减退(AIH - 胺碘酮诱导的甲状腺功能减退)都可能发生。AIT似乎在碘摄入量低的地区更频繁出现,而AIH在碘充足的地区更常见。已知有两种形式的AIT。它们的区分对于进一步的治疗程序非常重要。由于胺碘酮治疗期间甲状腺毒症和甲状腺功能减退的症状不明显,需要定期测定甲状腺功能。胺碘酮患者的正常范围与其他人群不同。本综述中列出了这些范围。AIT的治疗非常复杂。有时需要联合使用几种方法,特别是在不能停止胺碘酮治疗的情况下。